iShares MSCI United Kingdom (FTSE) vs Roivant Sciences Ltd. Common Shares — how do they compare? iShares MSCI United Kingdom (FTSE) trades at $46.52 (market cap $3.62B), while Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 6.8× iShares MSCI United Kingdom (FTSE)'s market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, iShares MSCI United Kingdom (FTSE) nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI United Kingdom (FTSE) for 46 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.
| EWU | ROIV | |
|---|---|---|
Market Cap | $3.62B | $24.72B |
Volume | 923,896 | 6,279,442 |
Sector | Broad Market / Factor | Health |
52-Week High | $49.39 | $41.81 |
52-Week Low | $41.34 | $16.04 |
Typical Hold Time | 46 Days | 1 Days |
Enterprise Value | — | $20.99B |
Signals from Pluang's Aura AI — not financial advice
EWU trades at $46.23, up 0.65% today, but technical indicators show a bearish trend with 16 sell signals versus 3 buy signals. The stock faces resistance at $47 and finds support at $45. Recent news highlights UK market volatility driven by rising gilt yields and inflation concerns, though some sectors like housebuilders have rallied on government support programs. Financial ratios remain unavailable in current data.
The outlook is cautious due to macroeconomic pressures from rising interest rates and energy costs. Investment opportunities exist in sector-specific rallies, but risks include prolonged inflation and ECB policy tightening. Stock performance hinges on UK economic stability and sectoral resilience amid global volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
EWU is a country-specific ETF that tracks the performance of the United Kingdom equity market. It provides exposure to large and mid-sized UK companies, with significant weightings in financials, energy, and healthcare, including Shell, AstraZeneca, and HSBC.
Read more on EWU →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →